Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2008

View Archived Issues

GenPhar avian influenza virus vaccines protective against H5N1challenge in mice

J-591 development proceeds after phase IIa study in androgen-independent prostate cancer

Studies of AER-002 in cystic fibrosis and COPD yield mixed results

Enclomiphene increases testosterone in men with adult idiopathic hyogonadotrophic hypogonadism

Improved adverse effect profile of Ono's novel anticholinergic bronchodilator

Global clinical SIR-Spheres microspheres trial launched in colorectal cancer

Newron completes patient enrollment in phase III safinamide study

Ardea provides update for non-nucleoside reverse transcriptase inhibitor program

Ariad initiates phase I trial of AP-24534 in patients with hematological cancers

Indevus licenses Canadian rights for Sanctura XR to Allergan

Wyeth and Progenics present preliminary results for two Relistor studies

Antitussive activity of SCH-255288 in several models of experimental cough

Novel 5-ASA derivative alleviates colonic inflammation and pain in mouse models

NPL-2005 awarded U.S. orphan drug status for fragile X syndrome

Lundbeck acquires European commercialization rights to Flurizan

New phase III data reported for Q-8003IR dual opioid therapy

Arixtra approved for new indication in Japan

Bayer Yakuhin obtains additional indication approval in Japan for Fludara

Encouraging phase I interim data reported for CG-0070 in bladder cancer

New therapeutic options for thrombotic disorders described in recent patents

Recent Roche and GSK patents disclose novel antiatherosclerotic agents

Novel treatments for neurological disorders reported in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.